Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

Lestari, Keri (55070933000); Sitorus, Trully (57217045210); Instiaty (55703138400); Megantara, Sandra (57105562100); Levita, Jutti (36133187800)
Lestari K.; Sitorus T.; Instiaty; Megantara S.; Levita J.
Molecular docking of quinine, chloroquine and hydroxychloroquine to angiotensin converting enzyme 2 (ACE2) receptor for discovering new potential COVID-19 antidote
Journal of Advanced Pharmacy Education and Research
Researches on drugs to be used for COVID-19 therapy are still challenging. SARS-CoV-2 uses the angiotensin-converting enzyme (ACE2) receptor to enter the human body. The S (spike) protein structure of SARS-CoV-2 interacts with the active site of ACE2 rece
ACE2 receptor; ARS-CoV-2; Chloroquine; COVID-19; Hydroxychloroquine; Quinine
K. Lestari; Department of Pharmacology and Clinical Pharmacy, Universitas Padjadjaran, Indonesia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.
SPER Publications
22493379
J. Adv. Pharm. Educ. Res.
Lestari K., Department of Pharmacology and Clinical Pharmacy, Universitas Padjadjaran, Indonesia; Sitorus T., Division of Pharmacology and Therapy, Department of Biomedical Sciences, Universitas Padjadjaran, Indonesia; Instiaty, Department of Pharmacology
Department of Pharmacology and Clinical Pharmacy, Universitas Padjadjaran, Indonesia; Division of Pharmacology and Therapy, Department of Biomedical Sciences, Universitas Padjadjaran, Indonesia; Department of Pharmacology and Therapeutics, Faculty of Medi
55070933000; 57217045210; 55703138400; 57105562100; 36133187800
13
2020
Article